We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...

The respiratory tract’s microbial microflora plays a significant role in determining the severity of RSV infections and the ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Capital Rx, a pharmacy benefit manager and administrator, has announced Judi Health, the first centralized claims processing ...

An expert discusses how key symptoms of narcolepsy, such as excessive daytime sleepiness and cataplexy, impact daily functioning and quality of life, along with the primary differences between type 1 ...

“We can point to situations where prior authorization has literally saved lives. There are good docs and there are bad docs ...

A novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or ...

The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...

A panelist discusses how the potential of neurokinin-targeted therapies to provide targeted symptom relief with fewer side effects represents a significant advancement in menopause care while noting ...

Using “cure” to refer to “obtaining a normal life” also fits — if you ignore previously lost education, career opportunities ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.